-
Product Insights
Follicular Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Follicular Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Follicular thyroid carcinoma is a cancer that forms in follicular cells of the thyroid. Follicular thyroid cancer constitutes 10 to 15% of all thyroid cancer cases, making it the second most common. Unlike differentiated types, undifferentiated types are rare. Diagnosis of follicular thyroid carcinoma relies on pathologic confirmation of follicular cells devoid of the nuclear atypia seen in papillary thyroid cancer,...
-
Product Insights
Lymphoproliferative Disorders - Drugs In Development, 2024
Empower your strategies with our Lymphoproliferative Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Lymphoproliferative disorders (LPD) constitute a diverse group of diseases marked by uncontrolled lymphocyte production, resulting in monoclonal lymphocytosis, lymphadenopathy, and bone marrow infiltration. Predominantly affecting immunocompromised individuals, these disorders involve two subsets of lymphocytes, T and B cells, leading to immunoproliferative disorders with inherent risks of immunodeficiency and lymphocyte dysregulation. Causative gene mutations, whether iatrogenic or acquired, are identified through somatic or...
-
Product Insights
Essential Thrombocythemia - Drugs In Development, 2024
Empower your strategies with our Essential Thrombocythemia – Drugs In Development, 2024 report and make more profitable business decisions. Essential thrombocythemia is a chronic myeloproliferative neoplasm in which cells in the bone marrow that produce the blood cells develop and function abnormally. In essential thrombocythemia, there is mainly an overproduction of platelet-forming cells (megakaryocytes) in the marrow. Symptoms of essential thrombocythemia include headache, dizziness, weakness or numbness on one side of the body, slurred speech, and transient ischemic attacks. The Essential...
-
Product Insights
Small Intestine Cancer - Drugs In Development, 2024
Empower your strategies with our Small Intestine Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Small intestine cancer, a rare malignancy, originates when malignant cells form in the tissues of the small intestine. This vital organ, composed of diverse cell types, gives rise to various cancer types. Adenocarcinomas, arising from gland cells lining the intestine, constitute approximately one-third of small intestine cancers. Carcinoid tumors, a subtype of neuroendocrine tumors, are generally slow-growing and the most prevalent...
-
Product Insights
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Drugs In Development, 2024
Empower your strategies with our Adrenocortical Carcinoma (Adrenal Cortex Cancer) – Drugs In Development, 2024 report and make more profitable business decisions. Adrenal cortex cancer (ACC) is a rare disease. It is caused by a cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. Predisposing factors include female sex, hereditary disease that affects the adrenal glands, age, and smoking. Symptoms include high blood sugar and pressure, muscle weakness in the legs, excessive weight gain in...
-
Product Insights
Pancreatic Tumor - Drugs In Development, 2024
Empower your strategies with our Pancreatic Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic cancer refers to the carcinoma arising from the pancreatic duct cells. Small changes in the cellular DNA result in uncontrolled multiplication and accumulation of cells into a tumor. Signs and symptoms of the most common form of pancreatic cancer may include yellow skin, abdominal or back pain, unexplained weight loss, light-colored stools, dark urine, and loss of appetite. Surgical resection is...
-
Product Insights
Hepatobiliary System Tumor - Drugs In Development, 2024
Empower your strategies with our Hepatobiliary System Tumor – Drugs In Development, 2024 report and make more profitable business decisions. A tumor in the hepatobiliary system is a disorder that affects the normal function of the system. The hepatobiliary system includes the liver, gallbladder, and bile ducts The Hepatobiliary System Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Hepatobiliary System Tumor, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Mammary Ductal Carcinoma - Drugs In Development, 2024
Empower your strategies with our Mammary Ductal Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Ductal carcinoma is a type of breast cancer that occurs in the milk ducts and moves into nearby tissues. There are two types of ductal carcinoma, invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS). If the abnormal cancer cells are seen inside the milk ducts, then it is DCIS. DCIS is also known as intraductal carcinoma or non-invasive ductal...
-
Product Insights
NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) - Drugs In Development, 2024
Empower your strategies with our NUT Midline Carcinoma (NMC or Nuclear Protein in Testis Midline Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare and aggressive cancer that can grow anywhere in the body. It is caused by rearrangement of the NUTM1 gene. Symptoms include fatigue, weight loss, a painless lump, pain, persistent cough, and shortness of breath. NMC is difficult to diagnose and treat. There...
-
Product Insights
Pediatric Cancer - Drugs In Development, 2024
Empower your strategies with our Pediatric Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Pediatric cancer types include leukemias, brain and other central nervous system (CNS) tumors, and lymphomas. Signs and symptoms include unexplained paleness and loss of energy, easy bruising or bleeding, limping, fever, and headaches. Diagnosis can be done by blood tests, biopsy, ultrasound, MRI, and PET-CT scan. Common treatments include surgery, chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. The Pediatric Cancer drugs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.